Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-Ht1a Agonists/5-Ht3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)

Chemical and Pharmaceutical Bulletin- Japan

doi 10.1248/cpb.57.34

Full Text

Abstract

Available in

Date

Authors

Publisher

Pharmaceutical Society of Japan

Related search

Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome

English

Serotonin (5-Ht1a) Receptor; Serotonin (5-Ht3) Receptor

Science-Business eXchange
2010English

The Role of Inflammation in Irritable Bowel Syndrome (IBS)

Journal of Inflammation Research
AllergyImmunology
2018English

Faecal Calprotectin as Part of Standardised Assessment Tool of Suspected Irritable Bowel Syndrome (IBS): A Novel Investigative Algorithm

Gut
Gastroenterology
2011English

Virtual Reality as a Treatment for Irritable Bowel Syndrome

2011English

Synthesis, Biological Evaluation and Molecular Modeling of 1-Oxa-4-Thiaspiro- And 1,4-Dithiaspiro[4.5]decane Derivatives as Potent and Selective 5-Ht1a Receptor Agonists

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2017English

Comparison of Various Treatment for Irritable Bowel Syndrome

BMJ
1980English

"Validation of Romanian Version of Visual Analogue Scale for Irritable Bowel Syndrome Questionnaire (VAS-IBS)"

BULLETIN OF INTEGRATIVE PSYCHIATRY
2020English

Efficacy and Safety of 5-Hydroxytryptamine 3 Receptor Antagonists in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Gastroenterology
HepatologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy